Citi stock neutral at UBS with $100 target as Banamex profitability lags

Citigroup is selling a 25% equity stake in its Mexican unit, Banamex, for approximately $2.3 billion, a strategic move aimed at simplifying its business model and reducing its global footprint. While UBS maintained a Neutral rating, highlighting Banamex's historical underperformance and limited contribution to Citi's future earnings (5% of 2027 consensus net income), other analysts like Truist Securities raised their price target to $112, maintaining a Buy rating, citing Citi's improved revenue and expense guidance. This partial divestiture, valued at 0.8x book, underscores Citi's ongoing efforts to enhance operational efficiency and financial outlook, despite the unit's past profitability challenges.

Analysis

Citigroup's strategic simplification is advancing with the sale of a 25% stake in its Banamex unit for approximately $2.3 billion, a transaction valued at a modest 0.8x book value and 0.95x tangible book value. This divestiture is part of a broader effort to streamline operations and reduce Citi's global footprint. Analysis from UBS highlights Banamex's historical underperformance, noting its average Return on Equity (ROE) of 9.5% from 2012 to mid-2025 has not recovered to pre-Global Financial Crisis levels of approximately 19%. The unit's annualized earnings of $966 million represent a relatively small portion, about 5%, of Citigroup's projected 2027 consensus net income, suggesting the sale's primary benefit is capital reallocation rather than a material loss of earnings. The market's reaction appears divided but leans positive; while UBS maintains a Neutral rating with a $100 price target, Truist Securities raised its target to $112 on a Buy rating, citing Citi's improved revenue and expense guidance for FY2025. This occurs as Citi's stock trades near its 52-week high following a 72% return over the past year, indicating significant investor optimism is already priced in.

Key Decisions for Investors

• Investors should view the Banamex stake sale as a positive execution on the bank's simplification strategy, though the key driver for further upside remains the successful implementation of its broader improved FY2025 cost and revenue guidance.
• It is prudent to monitor the valuation of the eventual full IPO or sale of the remaining Banamex stake and how management deploys the reallocated capital, as generating returns above the unit's historical 9.5% ROE is critical to validating the sale at a discount to book value.
• Given the stock's 72% appreciation over the past year, new positions should be considered in the context that much of the positive restructuring news and improved outlook may already be priced into the current valuation near its 52-week high.